Risk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction

Area of Science:

• Nephrology
• Cardiology
• Hematology

Background:

• Chronic kidney disease (CKD) is a significant risk factor for new-onset atrial fibrillation (AF), increasing stroke risk.
• Patients with end-stage renal disease (ESRD) on dialysis face heightened risks of both stroke and hemorrhage.
• Balancing anticoagulation benefits against bleeding risks is crucial for AF patients with CKD.

Approach:

• Review of existing studies on warfarin for stroke prevention in AF patients with ESRD.
• Analysis of the challenges in managing anticoagulation in renal dysfunction.
• Identification of the need for prospective, randomized trials.

Key Points:

• Renal dysfunction impairs coagulation and platelet function, raising hemorrhage risk.
• Warfarin's efficacy and safety in ESRD patients with AF remain uncertain due to inconsistent study results.
• Current evidence is insufficient to establish optimal stroke prevention strategies.

Conclusions:

• Optimal stroke prevention in AF patients with ESRD on dialysis is currently unknown.
• Further high-quality research, including randomized controlled trials, is necessary.
• Careful risk-benefit assessment is essential before initiating anticoagulation.